Concepedia

Author

Yunting Jian

Sun Yat-sen University Cancer Center

Also Known As

Y Jian, Yun-Ting Jian, Yunting Jian, Yun‐Ting Jian

33

Publications

811

Citations

17

H-Index

31

Concepts

All Affiliations

Sun Yat-sen University Cancer CenterSun Yat-sen UniversityGuangzhou Medical UniversityState Key Laboratory of Oncology in South ChinaThird Affiliated Hospital of Guangzhou Medical University
YJ

About

Yunting Jian is an author at Sun Yat-sen University Cancer Center specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

453

2

Cell Biology

11

12

453

3

Immunology

5

5

289

4

Health Sciences

1

1

23

5

Pathology

1

1

41

Yunting Jian

×

21

Publications

791

Citations

17

H-Index

YearCitations

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer

Dongni Shi, Xianqiu Wu, Yunting Jian,

Nature Communications

2022

181

Epigenetic silencing of <scp>SALL</scp> 2 confers tamoxifen resistance in breast cancer

Liping Ye, Chuyong Lin, Xi Wang,

EMBO Molecular Medicine

2019

81

ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer

Xiaoqing Sun, Zhen‐Yu He, Ling Guo,

Journal of Experimental & Clinical Cancer Research

2021

72

Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer

Meng Wang, Yue Li, Yunyun Xiao,

Nature Communications

2021

52

CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling

Chuyong Lin, Wenting Liao, Yunting Jian,

Oncogene

2017

45

Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway

Han Li, Weijing Zhang, Chunhao Niu,

International Journal of Cancer

2019

41

Resveratrol Enhances Etoposide‐Induced Cytotoxicity through Down‐Regulating <scp>ERK</scp>1/2 and <scp>AKT</scp>‐Mediated X‐ray Repair Cross‐Complement Group 1 (<scp>XRCC</scp>1) Protein Expression in Human Non‐Small‐Cell Lung Cancer Cells

Jen‐Chung Ko, Jhan‐Jhang Syu, Jyh‐Cheng Chen,

Basic & Clinical Pharmacology & Toxicology

2015

31

BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate

Xinjian Huang, Dongni Shi, Xuxiazi Zou,

Theranostics

2022

31

Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells

Jen‐Chung Ko, Hsien‐Chun Chiu, Jhan‐Jhang Syu,

Biochemical Pharmacology

2014

29

Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer

Yue Li, Meng Wang, Muwen Yang,

Cancer Research

2021

27

Page 1